KIANI & WASAG PHARMACEUTICS LTD

Company Registration Number:
07214213 (England and Wales)

Unaudited statutory accounts for the year ended 30 April 2023

Period of accounts

Start date: 01 May 2022

End date: 30 April 2023

KIANI & WASAG PHARMACEUTICS LTD

Contents of the Financial Statements

for the Period Ended 30 April 2023

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

KIANI & WASAG PHARMACEUTICS LTD

Company Information

for the Period Ended 30 April 2023




Director: Amir Raza Kiani
Registered office: Unit 38 Eurolink Business Centre
49 Effra Road
London
England
SW2 1BZ
Company Registration Number: 07214213 (England and Wales)

KIANI & WASAG PHARMACEUTICS LTD

Directors' Report Period Ended 30 April 2023

The directors present their report with the financial statements of the company for the period ended 30 April 2023

Principal Activities

Locum pharmacist

Directors

The directors shown below have held office during the whole of the period from 01 May 2022 to 30 April 2023
Amir Raza Kiani

This report was approved by the board of directors on 5 February 2024
And Signed On Behalf Of The Board By:

Name: Amir Raza Kiani
Status: Director

KIANI & WASAG PHARMACEUTICS LTD

Balance sheet

As at 30 April 2023


Notes

2023
£

2022
£
Fixed assets
Tangible assets: 4 3,440 4,195
Total fixed assets: 3,440 4,195
Current assets
Debtors: 5 34,875 35,719
Cash at bank and in hand: 51,945 38,870
Total current assets: 86,820 74,589
Creditors: amounts falling due within one year: 6 ( 7,682 ) ( 6,954 )
Net current assets (liabilities): 79,138 67,635
Total assets less current liabilities: 82,578 71,830
Total net assets (liabilities): 82,578 71,830

The notes form part of these financial statements

KIANI & WASAG PHARMACEUTICS LTD

Balance sheet continued

As at 30 April 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 82,478 71,730
Shareholders funds: 82,578 71,830

For the year ending 30 April 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 5 February 2024
And Signed On Behalf Of The Board By:

Name: Amir Raza Kiani
Status: Director

The notes form part of these financial statements

KIANI & WASAG PHARMACEUTICS LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

KIANI & WASAG PHARMACEUTICS LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 1 1

KIANI & WASAG PHARMACEUTICS LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

  • 3. Off balance sheet disclosure

    No

KIANI & WASAG PHARMACEUTICS LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

4. Tangible assets

Motor vehicles Total
Cost £ £
At 01 May 2022 4,195 4,195
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 30 April 2023 4,195 4,195
Depreciation
At 01 May 2022 - -
Charge for year 755 755
On disposals - -
Other adjustments - -
At 30 April 2023 755 755
Net book value
At 30 April 2023 3,440 3,440
At 30 April 2022 4,195 4,195

KIANI & WASAG PHARMACEUTICS LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

5. Debtors


2023
£

2022
£
Other debtors 34,875 35,719
Total 34,875 35,719

KIANI & WASAG PHARMACEUTICS LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

6.Creditors: amounts falling due within one year note


2023
£

2022
£
Taxation and social security 7,682 6,954
Total 7,682 6,954